According to a new report conducted by PricewaterhouseCoopers (PwC), China continues to lead India in outsourcing of clinical trials to Asia. Pharmatimes.com reports that while India has lead in the past, now China has 870 trials registered or underway compared with 737 trials in India.
Findings from the PwC report proves indications that were made last autumn that China was pulling ahead of India as a preferred location for clinical trials. Read the full article here.
Search This Blog
Blog Archive
-
▼
2008
(97)
-
▼
October
(16)
- India possibility for Australia's CROs Needs
- CRO Stock Prices Going Down
- CROs Open New Opportunities for Employment
- Clinical Outsourcing Spend is Going Down
- Reducing Costs and Time of Cancer Trials
- Pharma Companies Are Outsourcing Less of Clinical ...
- Are companies budgeting less towards their outsour...
- Averion expands in Eastern Europe
- New report focusing on outsourcing in central Europe
- ethica Clinical Research expands to South America
- Clincal Trials in India
- Clinical Trials Today: ethica Heads to South America
- Bridge Laboratories to Support NIDA
- Changing Face of CRO's
- Update to China’s Growing Lead in Clinical Outsour...
- China is Ahead of India in Outsourced Trials
-
▼
October
(16)
No comments:
Post a Comment